TGA Of Australia Probes Adverse Flu-Vaccine Effects In Youngest Kids
This article was originally published in PharmAsia News
Executive Summary
Australia's Therapeutic Goods Administration has launched a probe into whether the seasonal flu vaccine is safe for children under five years of age. The nation's chief medical officer advised physicians to cease giving the shots to children in that age group after seeing a sharp increase in adverse reactions in West Australia. The reports said the young children often experienced fever and convulsions in response to the inoculations. The vaccine was made by Australia's CSL, which has been asked by authorities to identify the batches sent to the Australian state and to test them. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.